Newcastle Disease Virus (PDQ®)
Cancer Information Summaries « English « Patients « N
Overview
- Newcastle disease virus (NDV) is a virus that is of interest because it replicates (makes copies of itself) more quickly in human cancer cells than in most normal human cells and because it can kill these host cells (see Question 1 ).
- NDV can be used to directly kill cancer cells, or it can be given as a cancer vaccine. Cancer vaccines cause the body’s natural immune system to seek out and destroy cancer cells (see Question 4 ).
- The results of clinical trials (research studies) of NDV as a cancer treatment have not proved that it works (see Question 6 ).
- The US Food and Drug Administration has not approved NDV as a treatment for cancer (see Question 8 ).
This record was last updated on March 16th, 2006.
About the PDQ Cancer Information Summaries from the National Cancer Institute
PDQ (Physician Data Query) is a comprehensive cancer database published by the National Cancer Institute (NCI), which is part of the National Institutes of Health (NIH). It contains peer-reviewed summaries on cancer treatment, screening, prevention, genetics, and supportive care, and complementary and alternative medicine; a registry of cancer clinical trials; and directories of physicians, professionals who provide genetics services, and organizations that provide cancer care.
The PDQ Cancer Information Summaries are peer reviewed and updated monthly by six editorial boards comprised of specialists in adult treatment, pediatric treatment, supportive care, screening and prevention, genetics, and complementary and alternative medicine. The Boards review current literature from more than 70 biomedical journals, evaluate its relevance, and synthesize it into clear summaries. Many of the summaries are also available in Spanish.
Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PDQ document.